NADPH oxidases (NOX) are enzymes that catalyze the production of reactive oxygen species (ROS). Four species of NOX catalytic homologs (NOX1, NOX2, NOX4, and NOX5) are reportedly expressed in vascular tissues. The pro-atherogenic roles of NOX1, NOX2, and their organizer protein p47 ph°x were manifested, and it was noted that the hydrogen peroxide-generating enzyme NOX4 possesses atheroprotective effects. Loss of NOX1 or p47 ph°x appears to ameliorate murine aortic dissection and subsequent aneurysmal diseases; in contrast, the ablation of NOX2 exacerbates the aneurysmal diseases. It is possible that the loss of NOX2 activates inflammatory cascades in macrophages in the lesions. Roles of NOX5 in vascular functions are currently undetermined, owing to the absence of this enzyme in rodents and the limitation of the experimental procedure. Thus, it is possible that the NOX family of enzymes exhibits heterogeneity in the atherosclerotic diseases. In this aspect, subtype-selective NOX inhibitor may be promising when NOX systems serve as a molecular target for atherosclerotic and aneurysmal diseases.
Introduction
NADPH oxidases (NOX) are enzymes that transfer electrons across biological membranes from NADPH. In general, the electron acceptor is oxygen, and the product of the enzymatic reaction is superoxide (O2 • ); thus, activation of NOX enzymes leads to generation of reactive oxygen species (ROS) [1] [2] [3] . Following the cloning of the gene that encodes NOX2 (Cybb) 4, 5) , the role of NOX systems in phagocytic and host defense functions including the respiratory burst was investigated 1, 6) . Non-phagocyte NOX homologs were subsequently identified and were functionally characterized in other cell types, including the cells that make up vascular components 7) . Despite the host defense functions of NOX2, numerous lines of research indicate that dysregulation of NOX isozymes, including NOX2, potentiates oxidative stress in inflamed lesions and exerts deleterious roles in a variety of inflammatory diseases 1, 3, 7) . Atherosclerosis, a chronic vascular disease characterized by functional and structural disorders in whole arterial trees, can be a cause of lethal cardiovascular events, such as myocardial infarction and stroke 8) . Pharmacotherapy with statins has been shown to reduce cardiovascular event rates significantly in randomized, placebo-controlled clinical trials in some cases; however, statins are not always sufficient for reducing the events 9) . For example, recurrent ischemic events following acute coronary syndrome occur in 20% of patients by 36 months after the primary events despite optimal cholesterol lowering therapy and medical care 10) . Thus, the molecules expressed in the vascular walls, which function as critical factors for direct control of atherosclerotic cardiovascular diseases, should be targeted to achieve better therapeutic outcomes. It is believed that ROS production in vascular walls has a pivotal role in atherogenesis; thus, the behavior and impact of NOX isozymes in atherogenesis have been extensively studied.
Abdominal aortic aneurysm (AAA), one of the representative atherosclerotic diseases, is a major cause of cardiovascular deaths and the tenth leading cause of death in men aged over 65 years in western coun-
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local. Accordingly, depending on the subcellular localization of NOX, O2 • is released either intracellularly or extracellularly, eliciting corresponding internal signaling or paracrine effects. Superoxide dismutase (SOD) rapidly converts O2 • to longer-lasting and membrane-permeable H2O2, leading to the distinct signal transduction and expanded range of action. Among seven species of NOX catalytic homologs, four of which (NOX1, NOX2, NOX4, and NOX5) are reportedly expressed in vascular tissues. For further details regarding the molecular basis of the NOX family, please refer the previous review articles [1] [2] [3] . Distinct roles of NOX isozymes in vascular functions are summarized below.
NOX1
Nox1 is expressed in vascular endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and adventitial fibroblasts at the plasma membrane, caveolae, and endosomes, and associates with p22 ph°x , p47 ph°x , Rac GTPases, and NOXA1 2, 3) ( Fig. 1) . In VSMCs, NOX1 is reportedly inducible and activatable by certain vasoactive agents as well as growth factors, including angiotensin (Ang ) 2) , basic fibroblast growth factor (bFGF) 19) , and platelet-derived growth factor (PDGF) 20) . Furthermore, NOX1 is inducible by the pro-atherogenic cytokines IFN-, which is mediated through Janus kinase/signal transducer and activator of transcription (JAK/STAT)-mediated transcriptional regulations 21) . Accordingly, dysregulation of this enzyme in VSMCs appears to tries 11) . The prevalence of AAA in the elderly has been estimated at 2.2% in a recent Swedish study 12) and at 4% to 8% in earlier studies in the USA, Australia, Denmark, and UK [13] [14] [15] [16] , with a mortality rate of 80% following AAA rupture 17) . Although AAA rupture is life threatening, molecular targets for this disease have not yet been identified. In turn, AAA is often treated surgically, with artificial vessels or stent grafts 18) . To reduce surgical exposure and its accompanying complications, various candidate molecules targeting AAA, including NOX isozymes, are currently undergoing experimental trials. In this brief review, we summarize the roles of NOX family enzymes in the regulation of vascular functions as well as the pathogenesis of atherosclerosis and AAA and discuss their functional heterogeneity.
NOX Family Enzymes and Vascular Function
NOX systems are composed of catalytic subunits (e.g., NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1, and DUOX2), a smaller membrane-bound protein that stabilizes the NOX subunit within membranes (p22 ph°x ), and up to three cytosolic regulatory subunits including an organizer protein (p47 ph°x or NOXO1), activator proteins (p67 ph°x or NOXA1), and small GTPases (Rac1 or Rac2) 1) . These systems stimulate the production of ROS, including O2 • and hydrogen peroxide (H2O2) 3) . Since O2 • is hardly permeable to biological membranes and is rapidly converted to other ROS, its working range is mostly A gene-targeting study showed that Nox4 deficiency delays recovery of blood flow in a femoral artery ligation model in mice, which is due to the reduction of angiogenic responses in ECs 51) . Furthermore, Nox4 deficiency in Ang -administrated mice suppressed NO • production and EC-dependent vasodilation and facilitated aortic wall thickening. Thus, it is likely that NOX4 and its product H2O2 in ECs have roles in vascular homeostasis even under the inflammatory conditions.
NOX5
NOX5 is structurally distinct from other NOX enzymes, since this isozyme contains an additional regulatory domain in its N-terminal. Unlike other NOX isozymes, additional subunits are unnecessary for NOX5 activity; alternatively, this isozyme is regulated by calcium binding to N-terminal EF-hands (Fig. 1) . NOX5 is detectable intracellularly in the cytoskeletal fraction, endoplasmic reticulum, and plasma membrane [52] [53] [54] . Since NOX5 is not expressed in rodents, this molecule has been analyzed mainly utilizing cultured cells and isolated tissues. It was reported that NOX5 participates in PDGF-induced proliferation through the JAK/STAT signals in VSMCs 55) . Furthermore, forced expression of NOX5 in ECs facilitates proliferation and angiogenic tube formations 52) . Contrarily, adenoviral-mediated transduction of NOX5 in isolated aortas potentiates production of O2 • , thereby accelerating consumption of EC-derived NO • . Accordingly, the forced expression of NOX5 in aortas impairs EC-dependent relaxation, and potentiated phenylephrine-induced contraction 56) . These results imply the potential regulatory roles of NOX5 in vascular function; however, the physiological and pathophysiological significance of endogenous NOX5 is currently unclear.
Roles of NOX Family in Atherosclerotic and
Aneurysmal Diseases
Atherosclerosis
Accumulating evidence showed that ROS-mediated oxidative stress in atherosclerotic lesions induces various inflammatory elements, such as endothelial adhesion molecules (e.g., ICAM-1, VCAM-1, E-selectin) and inflammatory cytokines and chemokines (e.g., IFN-, IL-1 , IL-6, MCP-1), through redox-sensitive transcription factors (e.g., NF-B and AP-1). Overexpression of adhesion molecules in ECs facilitates cause vascular disorders in vivo, such as hypertension 22, 23) , vascular hypertrophy 24) , and vascular inflammation 25, 26) , whereas its physiological functions remain largely elusive.
NOX2
NOX2, a superoxide generating enzyme, is expressed in every type of vascular component cells, except VSMCs, in large arteries, and associates with p22 ph°x , p47 ph°x , Rac GTPases, and p67 ph°x ( Fig. 1) 2, 3)
. ECs and adventitial fibroblasts are considered the primary sources of NOX2-derived superoxide, even in large arteries 10) . NOX2 can be activated by pathways similar to NOX1, such as phosphorylation of p47 ph°x by PKC and Src 27, 28) . In vitro experiments have shown that NOX2 is activable by the multiple classes of inflammatory cytokines, including IL-17 29) and IFN- 30) . Importantly, it was noted that NOX2-generated O2 • induces vascular constriction, since O2 • rapidly reacts with and neutralizes nitric oxide (NO • ), a robust EC-derived vasodilator. Indeed, NOX2 expression levels were inversely correlated with ECdependent vasodilation in isolated murine aortas 31) . The over-activation of NOX2 in vascular tissues may associate with vascular diseases, such as hypertension 2, [32] [33] [34] and pathological angiogenesis 35) .
NOX4
NOX4 is expressed in every type of resident cells in the vasculature 2, 3) and is distributed intracellularly in the perinuclear space or the endoplasmic reticulum in ECs 36, 37) , the nucleus in ECs 38) , and in focal adhesions and stress fibers in VSMCs 39) . NOX4 is thought to be constitutively active 40) , since NOX4 associates with p22 ph°x , but not with the stress response molecules p47 ph°x or Rac GTPases, unlike NOX1 and NOX2 (Fig. 1) . Accordingly, NOX4 ensures the baseline production of ROS, particularly H2O2. Earlier investigations identified transforming growth factoras an activator of NOX4 signals 41) . Cell-based experiments found that NOX4 mediates proliferation in pulmonary VSMCs 42, 43) . Furthermore, NOX4 elicits mitotic and anti-apoptotic actions in ECs [44] [45] [46] . Contrarily, presence of NOX4 appears to be necessary for maintaining VSMCs in the non-proliferative quiescent state and mediates TNF--induced apoptosis in ECs 28, 47, 48) . In addition to mitotic actions, roles of NOX4 in cell motility have been described. Indeed, silencing of Nox4 by siRNA reportedly impairs PDGF-induced migration in VSMCs 49) and wound closure in ECs 46) . However, it is also noted that Nox4 over-expression in VSMCs 49) or Ang -stimulated adventitial fibroblasts 50) decelerates cellular motility. Such opposite phenotypes regarding mitosis and bers to atherosclerosis, except for NOX5, has been mainly investigated by using gene-targeting techniques and atherosclerosis-prone mice, Apoe-null mice and Ldlr-null mice ( Fig. 2 59) . Gray et al. noted that atherosclerosis in Apoe-null mice is aggravated by streptozotocininduced diabetes, which is ameliorated by Nox1 deficiency or GKT137831, a specific orally active NOX inhibitor with a specificity for Nox1 and Nox4 60) . Amelioration of atherosclerosis by Nox1 deficiency was accompanied by the reduction of MCP-1 and VCAM-1 expression, thereby decreasing recruitment of macrophages. Furthermore, NOX2 is reportedly enriched in ECs and macrophages in the atherosclerotic lesions in Apoe-null mice, and generates excessive O2 • , leading to reduction of bioavailability of NO • 61) . Since NO • exerts potent atheroprotective effects 62) , deficiency of Cybb ameliorates atherosclerotic diseases in mice. In contrast, EC-specific transduction of Cybb accelerates macrophage recruitment to the atherosclerotic lesion in Apoe-null mice, whereas it does not affect the development of lesions 63) . Considering the predominance of inflammatory cytokines leukocyte adhesion to ECs, and MCP-1 potentiates cellular motility in monocytes/macrophages, thereby accelerating infiltration of those cells into the lesions. Pro-inflammatory cytokines mediate immune responses in immunocompetent cells, including T-cells and mast cells, in the lesions 57) . It is believed that excess activity of NOX family enzymes triggers such inflammatory responses in atherosclerotic lesions.
Sorescu et al. investigated the distribution of oxidative stress and NOX family in human atherosclerotic plaques 58) . Whereas oxidative stress was present homogenously throughout the intima, media, and adventitia in nonatherosclerotic coronary arteries, additional intense areas of oxidative stress were detectable in the shoulders of coronary plaques, which are enriched in macrophages and -actin-positive cells. p22 ph°x and NOX2 were co-expressed mainly in macrophages, whereas NOX4 was found only in nonphagocytic vascular cells. Expression of NOX2 and p22 ph°x mRNA was associated with the severity of atherosclerosis. NOX2 expression correlated with the plaque macrophage content while NOX4 expression correlated with the content of -actin-positive cells. NOX1 expression was marginal both in human coronary arteries and in isolated vascular cells.
Contribution of endogenous NOX family mem- atherogenesis in western-diet-fed Apoe-null mice, and that deficiency of Nox1 in mice leads to increasing plasma LDL/VLDL and triglyceride levels 66) . Furthermore, Nox4 deficiency in Apoe-null mice results in leukocyte adhesion to ECs and macrophage recruitment to atherosclerotic lesions, thereby accelerating atherogenesis 67) . This may be due to the activation of ECs by depletion of NOX4-derived H2O2, which is characterized by the induction of adhesion molecules and inflammatory cytokines in the cells. It was also reported that Nox4 deficiency did not change the development of atherosclerotic lesions in the streptozotocin-induced diabetic Apoe-null mice 60) . Collectively, NOX1 and NOX2 in vascular endothelium and its product O2 • exert deleterious roles in atherosclerosis, while NOX4 exhibits constitutive and protective effects even in the inflamed vasculature. It is noteworthy that the roles of NOX1 in atherogenesis are complicated, since deficiency of Nox1 in Apoe-null mice in atherosclerotic lesions 57) , it is suspected that the NOX system in the lesions is potentiated by pro-atherogenic cytokines, such as IFN-and IL-17. Zhao et al. documented that treatment of cultured endothelial cells with copper-oxidized LDL up-regulated NOX2 expression 64) . Furthermore, Bae et al. noted that minimally oxidized low-density lipoprotein, a potent exacerbator of atherosclerosis, facilitates NOX2-dependent generation of ROS in macrophages 65) . Such ROS generation appears to be mediated through the TLR4/ PLC /PKC axis. Thus, a variety of humoral stimuli, in addition to cytokines, may be responsible for the pro-atherogenic over-activation of NOX systems.
While several studies regarding atherosclerotic diseases employ the context that over-activation of vascular and myeloid NOX facilitate oxidative stress, thereby exacerbating the diseases as noted above, certain finding challenges this hypothesis. Sobey et al. recently showed that NOX1 activity is reduced during tory chain of enzymes 73) . Ballinger et al. noted that SOD2 regulates apoptotic signals in ECs and proliferation/apoptotic signals in VSMCs, and that the deficiency of SOD2 in Apoe-null mice facilitates the formation of atherosclerosis, which appears to be mediated through the mitochondrial DNA damage 76) . SOD3, a secreted Cu/Zn-containing SOD (ecSOD), is abundant in the extracellular space in the vascular tissue 73) and is mainly derived from macrophages/ foam cells as well as VSMCs and fibroblasts in human and mouse atheromas 77, 78) . Sentman et al. noted that ablation of SOD3 leads to a slight increase in atherosclerotic lesions in Apoe-null mice one month following initiation of an atherogenic diet, while such phenotypes of SOD3-deficient mice vanished after three months on the atherogenic diet or after eight months on standard chow 79) . Thus, it is likely that mitochondrial SOD2 is atheroprotective; however, the roles of SOD1 and SOD3 in atherosclerosis are still unclear.
Aneurysmal Diseases
Oxidative stress induces inflammatory responses even in aneurysmal lesions 80) . This facilitates accumulation of MMPs and subsequent remodeling of vascular tissues, which can be threshold process in some aneurysmal diseases 80) . Indeed, macrophage-and vascular cell-derived MMPs-9 and -12 are considered major exacerbators of aneurysmal diseases 81, 82) because they break down vascular structures, including the elastic lamellae and basement membrane, which leads to vascular dissection in some instances 80) . An early investigation suggested that feeding a diet enriched with antioxidant vitamin E reduces aortic dissection and subsequent aortic expansions in Ang -administrated Apoe-null mice 83) . Thus, oxidative stress facilitates pathogenesis of aneurysmal diseases in mice. In human subjects, induction of p22 ph°x -based NADPH oxidase and elevation of ROS are evidenced in aneurysmal aortic walls, which is significant in the vascular regions where chymase-positive mast cells and monocytes/macrophages were enriched 84) . MMP activity appears intense in such inflamed lesions 84) . Interestingly, multiple regression analysis showed that the therapeutic interventions using statin or angiotensin type I receptor blocker (ARB) abrogates p22 ph°x induction 84) . Other researchers showed that plasma malondialdehyde levels are elevated in patients with AAA compared with those in the control group, indicating systemic elevation of oxidative stress in AAA patients 85) . Oxidative stress in human AAA segments is reduced by either the addition of the NOX inhibitor apocynin or diphenyleneiodonium, the cyclooxygenase inhibitor indomethacin, or the nitric oxide synthase inhibitor L-NAME or 1400W 85) . Furtherworsens plasma dyslipidemia.
Plaque stability, which is characterized by the thickness of fibrous cap and the degree of inflammation as well as the amount of recruited macrophages in the plaques, is important to predict whether the plaque ruptures. It is well known that unstable plaques often trigger occlusive diseases, including atherothrombosis and acute coronary syndrome. Collagens constitute a major portion of the extracellular matrix in the atherosclerotic plaque and also modulate cellular responses through its specific receptor 68, 69) . Matrix metalloproteinases (MMPs), which are secreted from vascular resident cells and immune cells in the atherosclerotic lesions, are capable of degrading extracellular matrix, including collagen and fibronectin, thereby accelerating the remodeling of extracellular matrix 70) . Deficiency of Nox1 in Apoe-null mice potentiated the secretion of MMP9 and diminished the deposition of collagen and the recruitment of -SMA-positive cells into the lesions 66) . Similarly, Nox4 deficiency in Apoenull mice showed reduction of collagen contents in the lesions 67) , implying the possible contribution of those NOX family members to plaque stability. However, since the stability is hardly evaluated in the murine atherosclerosis models, the contribution of NOX family members to the plaque stability/instability, in particular in vivo, is currently uncertain.
There is no direct evidence regarding atherogenic or atheroprotective actions of NOX5. Nevertheless, cell-based experiments predicted the role of NOX5 in human atherosclerosis. Indeed, NOX5 variants were expressed in human THP-1 monocytes and primary CD14 monocytes and contributed to ROS generation 71) . NOX5 protein expression, which is inducible by interferon-and oxidized LDL, is localized to CD68 macrophage-enriched human atherosclerotic plaques. Thus, the roles of NOX5 in atherosclerosis are worthy to be evaluated in the future investigations.
SOD catalyzes the conversion of NOX-generated O2
•-to H2O2, and reportedly associates with vascular homeostasis 72) . The SOD family is comprised of three isozymes, SOD1, SOD2, and SOD3 73) . SOD1, which is expressed in vascular endothelium, is the major intracellular SOD (cytosolic Cu/ZnSOD), and SOD1 transgenic mice exhibit reduced Ang -induced oxidative stress, MCP-1 induction, and macrophage recruitment in the aorta 74) . Conversely, other research has reported that transduction of SOD1 in high fat dietfed mice potentiates the formation of atherosclerotic lesions 75) . Thus, the role of SOD1 in atherogenesis may vary depending on animal models. SOD2, which is a manganese (Mn) containing enzyme (MnSOD), is localized in the mitochondrial matrix and catalyzes the dismutation of O2
•-that is generated by the respira-deficiency of Nox1 reduces incidence of aortic dissection in Ang -infused wild type mice 89) . In this case, up-regulation of tissue inhibitor of metalloproteinase-1 (TIMP-1), an endogenous inhibitor of MMPs, is capable of suppressing MMP activity. Collectively, excess activity of NOX1 and its organizer protein p47 ph°x augment dissecting aneurysms by accelerating MMP-dependent ECM turnover.
Contribution of p47 ph°x to dissecting aneurysms 88) predicts the substantial effects of NOX2, another partner of p47 ph°x , on the disease. Indeed, Fan et al. noted that EC-specific transduction of exogenous CYBB (NOX2 gene) facilitates aortic dissection in Ang -infused mice 90) . We recently investigated the roles of endogenous NOX2 in dissecting aneurysms using gene-targeting study 91) . However, unexpectedly, systemic and myeloid-specific deficiency of Cybb promotes aortic expansion, but reduces the level of ROS in aneurysmal lesions in Ang -infused mice. Cybb deficiency stimulates macrophage conversion toward the M1 subset, enhancing expression of IL-1 and MMP-9/12 mRNA in lesions. Administration of a neutralizing antibody against IL-1 abolishes aneurysmal development in Cybb-deficient mice; thus, IL-1 may be key mediator for this phenotype. Isolated bone marrow-derived macrophages from Cybb-null mice could not generate ROS. Alternatively, IL-1 expression in peritoneal and bone marrow-derived macrophages, but not in peritoneal neutrophils, is substantially enhanced by Cybb deficiency, which is largely due to the up-regulation of STAT1 in the cells. Furmore, NADPH-stimulated production of ROS significantly correlated with diameter of AAA 85) . Expression levels of NOX1, NOX2, and NOX5 are elevated in the AAA segments in addition to p22 ph°x , while that of NOX4 declined; thus, NOX1, NOX2, and NOX5 may be candidate responsive enzymes in human AAA 85) . Gene-targeting studies have disclosed the subtype-specific contribution of NOX to aortic dissection and pathogenesis of aneurysmal diseases ( Table 2) . Contribution of NOX in AAA was mainly investigated by using an Ang -infused hyperlipidemic mouse model, which was established by Daugherty et al. 86) . It is noteworthy that aortic dissection frequently precedes aortic expansions in this animal model 87) ; thus, the term "dissecting aneurysm" is used in this manuscript instead of "AAA" when it applies to the mouse model. Ablation of Ncf1 (p47 ph°x gene) leads to the reduction of systolic blood pressure as well as the incidence of aortic expansion in Ang -administrated Apoe-null mice 88) . Co-administration of vasopressor phenylephrine together with Ang recovers blood pressure in Ncf1-deficient mice, whereas it does not affect the incidence and aortic expansion. This indicates that p47 ph°x potentiates dissecting aneurysms independently of blood pressure. Loss of p47 ph°x suppresses macrophage recruitment into aneurysmal lesions and activates MMP2. As a result, p47 ph°x -mediated ROS is likely to trigger over-activation of MMP2, which decays elastic lamella, thereby reducing vascular stiffness in the lesions. Similar to p47 ph°x , ; thus, the redundancy may be unique in phagocytes. It is noteworthy that NOX2 is expressed also in vascular endothelium in atherosclerotic lesions, and the lack of endothelial NOX2 improves bioavailability of NO
• , thereby suppressing the formation of lesions 61) . Although rising bioavailability of NO
• similarly ameliorates dissecting aneurysms in mice 95) , Cybb deficiency does not reduce dissecting aneurysms. Thus, macrophage over-activation, rather than recovery of NO
• bioavailability in the endothelium, may be predominant in the aneurysmal diseases in Cybb-deficient mice.
Cell-type-specific roles of NOX isozymes in dissecting aneurysms are summarized in Fig. 3 . Based on the gene-targeting data in mice, NOX2 in ECs 90) and NOX1 in VSMCs 89) may contribute to aortic dissection in the aorta. Whereas EC-specific transduction of Cybb is capable of inducing aortic ROS and adhesion thermore, MMP9 secretion in bone marrow-derived macrophages is constitutively elevated, owing to the up-regulation of NF-B signals. Thus, it appears that Cybb deficiency enhances multiple inflammatory cascades. Since MMP9 plays a leading role in maintaining ECM turnover in aneurysmal lesions 81) , up-regulation of MMP9 by Cybb deficiency may participate in the pathogenesis of dissecting aneurysms. Compensatory activation of phagocyte inflammatory systems by the loss of NOX2 is not surprisingly, since overactivation of phagocytes by ablation of NOX systems has been reported in the literature 1, [92] [93] [94] . Indeed, genetic defects in phagocytic NOX systems have been found to induce chronic granulomatous disease (CGD), with most CGD patients experiencing systemic sterile hyperinflammation 1) . A deficiency in Cybb or Ncf1 in mice was found to significantly upregulate LPS-induced IL-1 expression in lung, accompanied by the activation of AP-1 and NF-B transcriptional systems 92) . Moreover, a loss-of-function mutation in p47 ph°x causes inflammatory skin lesions in mice concomitant with the up-regulation of IL-1 , which are suppressed by the genetic reintroduction of wild-type p47 ph°x 93) . Monocytes from CGD patients lacking Ncf1 have been found to produce higher amounts of IL-1 in response to LPS than monocytes from healthy subjects, an increase likely owed to the up-regulation of caspase-1-based inflammasomes 94) . Thus, deficiency of phagocyte NOX systems is compensated by the alternative inflammatory signals related molecules, clinical approaches targeting specific molecules may be more promising. Based on animal experiments, it is possible that targeting NOX family molecules, except for NOX2 and NOX4, is beneficial as a therapy for atherosclerotic and aneurysmal diseases. Nevertheless, the adverse pro-inflammatory effects of non-subtype-selective NOX inhibitors should be carefully monitored when they serve as candidate drugs in the clinical trial. NADPH-binding component of the respiratory burst oxidase system: studies using neutrophil membranes from patients with chronic granulomatous disease lacking the beta-subunit of cytochrome b558. J Exp Med, 1994; 179: 291-297 7) Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, Shah AM: NADPH oxidases in cardiovasmolecules in murine aneurysmal lesions, thereby accelerating aortic dissection 90) , deficiency of endogenous Cybb does not reduce dissecting aneurysms 91) . Thus, it is thought that macrophage over-activation, rather than reduction of EC inflammation, may be significant in the formation of dissecting aneurysms in Cybb-deficient mice. In contrast, Nox1 deficiency results in the elevation of TIMP-1 expression and the reduction of aortic dissection. TIMP-1 is secreted by VSMCs; thus, NOX1 in VSMCs potentially augments aortic dissection.
Our data shows that over-activation of macrophages by Cybb deficiency accelerates pathogenesis of dissecting aneurysms 91) , although the deficiency of Ncf1 reportedly ameliorates the diseases 88) . Whereas the reasons for the opposite aneurysmal phenotypes between Cybb-and Ncf1-deficient mice are currently unknown 88, 91) , we speculate that the suppression of NOX1, another partner of p47 ph°x , contributes to the ameliorative phenotypes of Ncf1-deficient mice. The compensatory over-activation of macrophages by Nox1 deficiency was not reported so far 89) , while deficiency of Ncf1 as well as Cybb reportedly leads to the over-activation of the inflammatory cascades in macrophages. It was reported that NOX1 is abundant in VSMCs but not in macrophages 1) and is largely responsible for the production of superoxide in VSMCs 96) . Consistently, Nox1 deficiency influences the VSMC functions during Ang -induced aortic dissection in mice 89) . In contrast, NOX2 activity appears to be predominant in phagocytes rather than VSMCs 96) . Accordingly, Cybb deficiency mainly influences macrophage functions in the murine dissecting aneurysms 91) . Thus, it is likely that Ncf1 deficiency leads to the phenotypic changes in both VSMCs and macrophages, which are due to the dysfunction of NOX1 and NOX2, respectively. Considering the amelioration of dissecting aneurysms in Ncf1-deficient mice 88) , it is speculated that the harmful redox action of NOX1 in VSMCs, rather than the anti-compensatory action of NOX2 in macrophages, is dominant in aneurysmal lesions. While NOX1 and NOX2 are expressed in vascular endotheium 1) , the contribution of those NOX isozymes to EC functions during dissecting aneurysm is still enigmatic 89, 91) .
Conclusive Remarks
A recent meta-analysis showed that antioxidants, such as vitamin E and -carotene, failed to prevent the development of atherosclerosis and related cardiovascular events 97) , suggesting that antioxidants may be clinically ineffective in patients with atherosclerotic diseases. Considering the functional diversity of redox-
